Compare Huntington Bancshares Incorporated (HBAN) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Bancshares Incorporated vs Inovio Pharmaceuticals Inc — how do they compare? Huntington Bancshares Incorporated trades at $18.13 (market cap $36.62B), while Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M). The key difference: Huntington Bancshares Incorporated is far larger — about 410.2× Inovio Pharmaceuticals Inc's market cap, and Huntington Bancshares Incorporated pays a 3.43% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| HBAN | INO | |
|---|---|---|
Market Cap | $36.62B | $89.27M |
Sector | Financials | Health |
52-Week High | $19.27 | $2.87 |
52-Week Low | $15.02 | $1.05 |
Dividend Yield | 3.43% | — |
Enterprise Value | — | $60.28M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
